Bilcare Ltd

Bilcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bilcare Ltd

₹ 64.4 3.55%
01 Jun - close price
bilcare-group.com BSE: 526853 NSE: BI
About

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

Key Points

Bilcare Resolution Update[1]
Company had been in default since 2013 and was admitted to NCLT proceedings in 2019. In 2023, it settled its dues through a one-time settlement, wherein Caprihans India Ltd.It's subsidiary leveraged its balance sheet to acquire compay's operating assets, enabling company to repay its lenders.

Website BSE NSE
  • Market Cap ₹ 152 Cr.
  • Current Price ₹ 64.4
  • High / Low ₹ 116 / 50.0
  • Stock P/E 58.9
  • Book Value ₹ 179
  • Dividend Yield 0.00 %
  • ROCE 1.00 %
  • ROE 0.61 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.36 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -53.2% over past five years.
  • Promoter holding is low: 30.0%
  • Company has a low return on equity of -0.49% over last 3 years.
  • Contingent liabilities of Rs.714 Cr.
  • Earnings include an other income of Rs.17.4 Cr.
  • Working capital days have increased from 1,735 days to 2,541 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Research, Analytics & Technology

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
4.62 3.66 4.59 5.06 4.29 4.87 2.76 3.36 4.13 2.07 1.85 1.73 1.20
10.91 5.11 6.64 6.28 8.68 5.72 5.49 3.88 5.70 3.48 3.21 3.47 9.18
Operating Profit -6.29 -1.45 -2.05 -1.22 -4.39 -0.85 -2.73 -0.52 -1.57 -1.41 -1.36 -1.74 -7.98
OPM % -136.15% -39.62% -44.66% -24.11% -102.33% -17.45% -98.91% -15.48% -38.01% -68.12% -73.51% -100.58% -665.00%
517.91 15.70 -1.81 0.33 5.23 3.84 3.78 3.78 6.45 6.72 3.45 5.46 1.74
Interest 0.20 0.16 0.08 0.19 2.06 0.63 3.04 0.12 0.06 0.14 0.17 0.15 0.14
Depreciation 1.67 0.44 0.52 0.56 0.63 0.73 0.77 0.77 0.60 0.68 0.72 0.71 0.61
Profit before tax 509.75 13.65 -4.46 -1.64 -1.85 1.63 -2.76 2.37 4.22 4.49 1.20 2.86 -6.99
Tax % 22.70% 1.68% -9.42% -5.49% 34.59% 14.11% -6.88% 23.63% 20.38% 20.04% 13.33% 5.24% -9.16%
394.04 13.42 -4.04 -1.55 -2.49 1.40 -2.57 1.81 3.36 3.59 1.04 2.71 -6.35
EPS in Rs 167.35 5.70 -1.72 -0.66 -1.06 0.59 -1.09 0.77 1.43 1.52 0.44 1.15 -2.70
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
331.33 315.42 285.60 257.53 239.81 211.75 304.16 429.79 13.98 17.60 15.12 6.85
310.30 300.30 288.45 257.77 238.89 219.34 279.00 393.05 21.12 26.71 20.79 19.34
Operating Profit 21.03 15.12 -2.85 -0.24 0.92 -7.59 25.16 36.74 -7.14 -9.11 -5.67 -12.49
OPM % 6.35% 4.79% -1.00% -0.09% 0.38% -3.58% 8.27% 8.55% -51.07% -51.76% -37.50% -182.34%
4.36 -105.57 73.52 259.53 5.59 38.18 66.58 42.55 515.03 19.45 17.85 17.37
Interest 131.84 31.73 47.82 55.53 72.10 69.08 74.72 68.19 0.45 2.49 3.85 0.60
Depreciation 105.52 101.29 79.23 304.34 248.47 88.06 34.63 34.64 4.52 2.15 2.87 2.72
Profit before tax -211.97 -223.47 -56.38 -100.58 -314.06 -126.55 -17.61 -23.54 502.92 5.70 5.46 1.56
Tax % -13.35% -65.00% 16.94% -20.52% 0.38% -19.15% -110.11% -24.47% 22.30% 6.32% 26.74% 36.54%
-183.68 -78.22 -65.93 -79.94 -315.25 -102.32 1.78 -17.78 390.79 5.34 4.00 0.99
EPS in Rs -78.01 -33.22 -28.00 -33.95 -133.89 -43.46 0.76 -7.55 165.97 2.27 1.70 0.42
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -32%
5 Years: -53%
3 Years: -21%
TTM: -55%
Compounded Profit Growth
10 Years: -24%
5 Years: 15%
3 Years: 32%
TTM: 21%
Stock Price CAGR
10 Years: 4%
5 Years: 3%
3 Years: 11%
1 Year: -22%
Return on Equity
10 Years: -32%
5 Years: -4%
3 Years: 0%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 23.55 23.55 23.55 23.55 23.55 23.55 23.55 23.55 23.55 23.55 23.55 23.55
Reserves 643.47 598.97 532.92 453.08 137.88 35.63 37.17 19.86 386.86 392.11 396.13 397.34
1,151.44 975.70 898.21 856.59 867.63 708.56 678.41 689.92 7.52 10.29 10.82 11.87
802.28 441.11 517.98 284.84 346.08 204.85 189.19 193.25 36.24 34.54 21.72 22.36
Total Liabilities 2,620.74 2,039.33 1,972.66 1,618.06 1,375.14 972.59 928.32 926.58 454.17 460.49 452.22 455.12
1,217.32 1,176.79 1,147.47 843.72 593.73 506.21 472.60 445.82 16.25 63.41 60.61 57.62
CWIP 124.66 0.00 0.00 0.25 0.28 0.00 0.08 0.00 0.00 0.00 0.00 0.00
Investments 682.43 552.73 552.88 514.03 513.37 173.17 89.49 80.51 293.51 293.52 293.52 309.71
596.33 309.81 272.31 260.06 267.76 293.21 366.15 400.25 144.41 103.56 98.09 87.79
Total Assets 2,620.74 2,039.33 1,972.66 1,618.06 1,375.14 972.59 928.32 926.58 454.17 460.49 452.22 455.12

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-16.68 28.44 37.28 7.17 62.13 71.12 -0.41 46.29 397.43 97.63 2.36
-14.39 8.62 -48.08 78.31 1.51 10.82 85.02 5.59 180.97 -107.06 2.94
22.55 -35.07 6.24 -86.70 -60.25 -83.03 -82.28 -55.47 -570.93 -0.51 -3.85
Net Cash Flow -8.51 1.98 -4.56 -1.22 3.39 -1.08 2.33 -3.59 7.47 -9.94 1.45
Free Cash Flow -33.84 28.06 -12.63 6.33 62.65 70.86 0.70 45.01 791.28 -10.14 4.98
CFO/OP -77% 190% -1,328% -3,388% 6,850% -948% -6% 129% -5,581% -1,065% -21%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 79.96 69.13 62.11 57.94 56.41 67.40 86.74 78.67 246.73 101.41 82.32 108.70
Inventory Days 214.55 85.46 50.98 50.90 68.40 56.55 85.32 71.21 60.10 21.27 30.02 37.12
Days Payable 180.64 77.49 86.11 114.26 155.62 128.77 116.24 100.16 439.03 91.35 154.06 435.11
Cash Conversion Cycle 113.87 77.11 26.99 -5.42 -30.82 -4.82 55.82 49.72 -132.20 31.33 -41.72 -289.29
Working Capital Days -327.69 -459.92 -555.87 -294.55 -395.82 -356.45 -178.42 -134.43 -640.97 1,135.23 1,529.52 2,540.61
ROCE % -4.11% -4.38% -5.02% -20.87% -20.40% -9.08% 0.34% 1.51% -1.38% -1.97% 1.58% 1.00%

Insights

In beta
Mar 2015 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
New Patent Applications Filed
Number

Log in to view insights

Please log in to see hidden values.

Login
Patents Granted
Number
Number of Permanent Employees
Number
Capacity Utilization
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01%
0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
69.95% 69.94% 69.95% 69.95% 69.95% 69.95% 69.95% 69.95% 69.95% 69.94% 69.95% 69.95%
No. of Shareholders 21,69119,87519,18119,11618,78318,24118,49617,58617,04716,51316,06815,824

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings